Physician profile
David Okwudi Okonkwo
NPI 1447204854
$2,307,770.69
in general payments reported to CMS, 2019-2025
23 companies · $304K in 2025
The $304K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369K · 2020: $621K · 2021: $391K · 2022: $317K · 2023: $158K · 2024: $148K · 2025: $304K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $315K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $165K · Royalty Or License: $103K · Travel and Lodging: $22K · Food and Beverage: $5,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $314,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $165,103.11 |
| Royalty Or License | $102,697.26 |
| Travel and Lodging | $22,163.78 |
| Food and Beverage | $5,263.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,404,100.33 | 2019-2023 | Xlif, Modulus, Reline |
| Globus Medical, INC. | $442,022.96 | 2019-2025 | Reline, Xlif, Modulus |
| Zimmer Biomet Holdings, INC. | $400,269.79 | 2019-2020 | |
| Zimvie INC. | $31,875.34 | 2022-2023 | |
| Stryker Corporation | $9,453.90 | 2019-2023 | Spinemap |
| Highridge Medical LLC | $7,535.38 | 2024-2025 | Trelloss-C Sa, Spine-None |
| Siemens Medical Solutions USA, INC. | $6,000.00 | 2019 | |
| Medtronic, INC. | $2,975.22 | 2021-2025 | Stealthstation S8 Platform, Mazor X System, Midas Rex |
| Natus Medical Incorporated | $1,672.42 | 2021 | |
| Mml US, INC. | $621.87 | 2021-2023 | Reactiv8 |
| Alphatec Spine, INC | $320.67 | 2024-2025 | Other - Miscellaneous |
| Abbott Laboratories | $303.83 | 2019 | |
| Amgen INC. | $140.36 | 2024 | Evenity |
| Ebi, LLC | $134.68 | 2025 | |
| Medical Device Business Services, INC. | $118.16 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $109.19 | 2021-2024 | Teligen |
| Innovation Technologies INC | $64.01 | 2021 | |
| Integra Lifesciences Corporation | $52.58 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,407,596.70 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Okonkwo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.